RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31185214http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31185214http://www.w3.org/2000/01/rdf-schema#comment"Diffuse large B cell lymphomas (DLBCLs) are genetically heterogeneous and highly proliferative neoplasms derived from germinal center (GC) B cells. Here, we show that DLBCLs are dependent on mitochondrial lysine deacetylase SIRT3 for proliferation, survival, self-renewal, and tumor growth in vivo regardless of disease subtype and genetics. SIRT3 knockout attenuated B cell lymphomagenesis in VavP-Bcl2 mice without affecting normal GC formation. Mechanistically, SIRT3 depletion impaired glutamine flux to the TCA cycle via glutamate dehydrogenase and reduction in acetyl-CoA pools, which in turn induce autophagy and cell death. We developed a mitochondrial-targeted class I sirtuin inhibitor, YC8-02, which phenocopied the effects of SIRT3 depletion and killed DLBCL cells. SIRT3 is thus a metabolic non-oncogene addiction and therapeutic target for DLBCLs."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.org/dc/terms/identifier"doi:10.1016/j.ccell.2019.05.002"xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Chen Z."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Chiang Y.L."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Cantley L.C."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Hu J."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Jing H."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Li M."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Lin H."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Hong J.Y."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Shen H."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Wang L."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Green M.R."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Cross J.R."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Jain N."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Cerchietti L."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Lyssiotis C.A."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Melnick A.M."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Duy C."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Mistry S.J."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/author"Teater M.R."xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/name"Cancer Cell"xsd:string
http://purl.uniprot.org/citations/31185214http://purl.uniprot.org/core/pages"916-931.e9"xsd:string